Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...

Recent health-related developments include Britain's decisions on the bioethanol industry, Berkshire Hathaway's new stake in ...

A draft of the Trump administration’s highly anticipated blueprint on health policy takes a softer approach to regulating companies than many had feared, a relief for industry and setback for ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

U.S. equities were mixed at midday following the release of the July retail sales report, which came in as expected.

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

A spokesperson for Hims did not immediately respond to a request for comment. The company previously said it was cooperating ...

The disclosure in a filing Thursday gave a much-needed boost to the beleaguered health insurance giant, which saw shares jump as much as 9.6% in post-market trading. In other news: Nike co-founder ...

Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...

Berkshire Hathaway invests in UnitedHealth; FTC investigates Hims & Hers for advertising practices; U.S. health department ...

Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...